Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last session and the average volume of the stock remained 3.51 … Continue reading Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Chris Lewis03/1403/14

Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -4.14% in last session and finished the day at $5.10. Traded volume was 3,687,994 million shares in the last session and the average volume of the … Continue reading Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

Mark DeFrance03/1103/11

Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Peregrine Pharmaceuticals (NASDAQ:PPHM) announced its earnings results on Friday. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session and the average volume of the stock remained 4.31million shares. The beta of the … Continue reading Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Kristen Barton03/1003/10

NASDAQ Bearish Stocks: CytRx Corporation (NASDAQ:CYTR), Alaska Communications Systems (NASDAQ:ALSK), VimpelCom (NASDAQ:VIP), Ambarella Inc (NASDAQ:AMBA)

CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -6.17% in last session and finished the day at $5.32. Traded volume was 3,186,360 million shares in the last session and the average volume of the … Continue reading NASDAQ Bearish Stocks: CytRx Corporation (NASDAQ:CYTR), Alaska Communications Systems (NASDAQ:ALSK), VimpelCom (NASDAQ:VIP), Ambarella Inc (NASDAQ:AMBA)

John Bellich03/1003/10

What’s Hot: Bellatrix Exploration Ltd. (NYSE:BXE), Ametek Inc. (NYSE:AME), McDonald’s Corp. (NYSE:MCD), CytRx Corporation (NASDAQ:CYTR), Pacific Continental Corp. (NASDAQ:PCBK)

Bellatrix Exploration (NYSE:BXE) had its target price decreased by BMO Capital Markets from C$4.75 to C$3.75 in a report issued on Monday. They currently have a market perform rating on the stock. Bellatrix Exploration Ltd. (NYSE:BXE) belongs to Basic Materials sector. Its weekly performance is -18.82%. On last trading day company shares ended up $2.07. Bellatrix Exploration Ltd. (NYSE:BXE) distance from 50-day simple moving average … Continue reading What’s Hot: Bellatrix Exploration Ltd. (NYSE:BXE), Ametek Inc. (NYSE:AME), McDonald’s Corp. (NYSE:MCD), CytRx Corporation (NASDAQ:CYTR), Pacific Continental Corp. (NASDAQ:PCBK)

Adam Keintzel01/2901/29

Investors Alert: Extreme Networks Inc. (NASDAQ:EXTR), The Dow Chemical Company (NYSE:DOW), PhotoMedex, Inc. (NASDAQ:PHMD), CytRx Corporation (NASDAQ:CYTR), Allied Nevada Gold Corp. (NYSEMKT:ANV)

Extreme Networks Inc. (NASDAQ:EXTR) on Tuesday reported a loss of $19.3 million in its fiscal first quarter. The San Jose, California-based company said it had a loss of 20 cents per share. Losses, adjusted for amortization costs and stock option expense, came to 1 cent per share. Extreme Networks Inc. (NASDAQ:EXTR) in last trading activity moved up 10.00% to close at $3.63. Company weekly performance … Continue reading Investors Alert: Extreme Networks Inc. (NASDAQ:EXTR), The Dow Chemical Company (NYSE:DOW), PhotoMedex, Inc. (NASDAQ:PHMD), CytRx Corporation (NASDAQ:CYTR), Allied Nevada Gold Corp. (NYSEMKT:ANV)

Mark DeFrance10/30